Aspect Biosystems

Bioprinting Tissue Therapeutics

Vancouver, Canada · Founded 2013 · $202.8M raised

Headquarters
Vancouver
Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$202.8M
Last Round
$115.0M Series BJan 2025
Rounds
3

About

Aspect Biosystems is a Canadian biotechnology company founded in 2013 at the University of British Columbia, pioneering the development of bioprinted tissue therapeutics. The company uses proprietary microfluidic bioprinting technology to create implantable tissues designed to replace, repair, or supplement biological function. Their lead programs target metabolic and endocrine diseases, and they have partnered with Novo Nordisk and raised over US$350M in capital.

Summary

Aspect Biosystems is a Biotech company based in Vancouver, Canada, founded in 2013. It has raised $202.8M in total across 3 rounds, most recently a $115.0M Series B round in Jan 2025. Investors include Dimension Capital, Government of Canada and Government of British Columbia.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BJan 2025
$115.0M

Sign up to see all 3 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aspect Biosystems on Indexed.vc
<a href="https://indexed.vc/companies/aspect-biosystems"><img src="https://indexed.vc/api/badge/company/aspect-biosystems" alt="Aspect Biosystems on Indexed.vc" width="260" height="76" /></a>